According to market research study published by Gen Consulting Company, the market size of the global smart insulin pens sector is expected to rise by USD 73 million with a CAGR of 10.3% by the end of 2028.
The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global smart insulin pens market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the smart insulin pens industry.
This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the product, distribution channel, and region. The global market for smart insulin pens can be segmented by product: connecting device, smart pen. Smart insulin pens market is further segmented by distribution channel: hospitals and pharmacies, online. Based on region, the smart insulin pens market is segmented into: North America, Asia Pacific, Europe, Rest of the World (ROW).
By product:
– connecting device
– smart pen
By distribution channel:
– hospitals and pharmacies
– online
By region:
– North America
– Asia Pacific
– Europe
– Rest of the World (ROW)
The report has also analysed the competitive landscape of the global smart insulin pens market with some of the key players being Companion Medical, Inc. (Medtronic plc), Diamesco Co., Ltd., Digital Medics Pty Ltd., Eli Lilly and Company, Emperra GmbH E-Health Technologies, Novo Nordisk A/S, pendiq GmbH, Ypsomed Holding AG, among others.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
Historical & Forecast Period
This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.
Scope of the Report
– To analyze and forecast the market size of the global smart insulin pens market.
– To classify and forecast the global smart insulin pens market based on product, distribution channel, region.
– To identify drivers and challenges for the global smart insulin pens market.
– To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global smart insulin pens market.
– To identify and analyze the profile of leading players operating in the global smart insulin pens market.
Why Choose This Report
– Gain a reliable outlook of the global smart insulin pens market forecasts from 2022 to 2028 across scenarios.
– Identify growth segments for investment.
– Stay ahead of competitors through company profiles and market data.
– The market estimate for ease of analysis across scenarios in Excel format.
– Strategy consulting and research support for three months.
– Print authentication provided for the single-user license.
| REPORT ATTRIBUTE | DETAILS |
|---|---|
| Base Year | 2021 |
| Forecast Year | 2022-2028 |
| CAGR (2022-2028) | 10.3% |
| Pages | 85 |
| Key Players | Companion Medical Inc. (Medtronic plc), Diamesco Co. Ltd., Digital Medics Pty Ltd., Eli Lilly and Company, Emperra GmbH E-Health Technologies, Novo Nordisk A/S, pendiq GmbH, Ypsomed Holding AG |
The global urology laser market is estimated to increase at the rate of 5.6% each year in the period from 2023 to 2029. Urology lasers are medical devices specifically designed…
The global scar management market, in terms of revenue, is anticipated to progress at a CAGR of 5.8% during the forecast period, 2023-2029. Scar management encompasses various techniques and treatments…
According to the latest estimates, the global diagnostic enzymes market is predicted to be growing at a CAGR of over 4.1% from 2023 to 2029. Diagnostic enzymes are a crucial…
Please fill out our form and we will get back to you.